Prothena | PRTA - Cash And Equivalent

Prothena reported $710.41M in Cash and Equivalent for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US USD 114.85M 40M
Agios Pharmaceuticals AGIO:US USD 139.26M 16.81M
Akebia Therapeutics AKBA:US USD 90.47M 54.29M
ALKERMES ALKS:US USD 740.08M 476.12M
Alnylam Pharmaceuticals ALNY:US USD 866.39M 206.83M
Amgen AMGN:US USD 9.3B 197M
Biogen BIIB:US USD 3.42B 256.3M
Biomarin Pharmaceutical BMRN:US USD 724.53M 36.98M
Bluebird Bio BLUE:US USD 66.48M 15.02M
Exelixis EXEL:US USD 501.2M 174.09M
Intercept Pharmaceuticals ICPT:US USD 50.52M 62.68M
Intra Cellular Therapies ITCI:US USD 148.61M 13.26M
IONIS PHARMACEUT IONS:US USD 276.47M 38.52M
Macrogenics MGNX:US USD 108.88M 24.89M
Nektar Therapeutics NKTR:US USD 88.23M 17.53M
Neurocrine Biosciences NBIX:US USD 262.9M 50.7M
Prothena PRTA:US USD 710.41M 214.78M
Regeneron Pharmaceuticals REGN:US USD 14.33B 10.84B
Seattle Genetics SGEN:US USD 319.94M 42.66M
Ultragenyx Pharmaceutical RARE:US USD 132.94M 258.71M
Vertex Pharmaceuticals VRTX:US USD 10.78B 1.61B
Vital Therapies VTL:US USD 106.74M 33.97M
YTE INCY:US USD 2.95B 260.8M